Related Experiment Video
Updated: Jul 2, 2026
08:02
Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
Published on: April 25, 2016
Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis
Rasa Kazlauskaite1, Arthur T Evans, Carmen V Villabona
1John H. Stroger Jr. Hospital of Cook County and Rush Medical College, M.Sc., 1900 West Polk Street, Room 806, Chicago, Illinois 60612, USA. rasa_kazlauskaite@rush.edu
The Journal of Clinical Endocrinology and Metabolism
|August 14, 2008
Summary
The low-dose corticotropin test is superior for diagnosing hypothalamic-pituitary adrenal insufficiency (HPAI) compared to the standard-dose test. This meta-analysis confirms its improved diagnostic accuracy for chronic HPAI.
Area of Science:
- Endocrinology
- Diagnostic Test Evaluation
- Clinical Research
Background:
- The diagnostic accuracy of tests for hypothalamic-pituitary adrenal insufficiency (HPAI) remains a subject of debate.
- Accurate diagnosis of HPAI is crucial for appropriate patient management and treatment.
Purpose of the Study:
- To compare the diagnostic performance of standard-dose versus low-dose corticotropin stimulation tests for HPAI.
- To evaluate the utility of these tests in diagnosing chronic HPAI.
Main Methods:
- A systematic literature search was conducted on PubMed (1966-2006) for relevant studies.
- Patient-level data from eligible studies (n>10 patients, confirmed HPAI suspicion, accepted reference standard) were included.
- Receiver operator characteristic (ROC) curves were constructed, and meta-analysis was performed to compare diagnostic values (Area Under Curve - AUC).
Main Results:
- Patient-level data from 13 studies (679 subjects) were analyzed.
- The low-dose corticotropin test demonstrated a higher AUC (0.92) compared to the standard-dose test (0.79).
- In a subset of studies with paired data (254 subjects), the low-dose test showed superior diagnostic value (AUC 0.94 vs. 0.85, P<0.001).
Conclusions:
- The low-dose corticotropin test is diagnostically superior to the standard-dose test for identifying chronic HPAI.
- Despite its improved accuracy, the low-dose test has identified technical limitations that warrant consideration.
Related Concept Videos
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:37Hypothalamic-Pituitary Axis
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
01:27Adrenal Gland Disorders
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
01:31Hormones of the Adrenal Glands
Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
01:24Physiological Foundation of Stress
Stress triggers a coordinated physiological response involving the sympathetic nervous system (SNS) and the hypothalamic-pituitary-adrenal (HPA) axis. This dual activation ensures that the body is prepared for both immediate and prolonged stress management. The process begins with the perception of a stressor. This initial phase activates the SNS, leading to the rapid release of adrenaline (epinephrine) from the adrenal glands.
Role of the Sympathetic Nervous System
Adrenaline triggers the...
Role of the Sympathetic Nervous System
Adrenaline triggers the...